PDE10A and juvenile Huntington disease: showed that inhibiting the enzyme phosphodiesterase 10A (PDE10A) with the drug papaverine improved spatial and recognition memories in mouse models of Huntington’s disease, possibly via increasing cAMP levels and activating the hippocampal PKA signaling (163).